Navigation Links
Royalty Pharma Statement Regarding Elan Proposal
Date:3/6/2013

NEW YORK, March 6, 2013 /PRNewswire/ -- RP Management, LLC ("Royalty Pharma") remains committed to acquiring Elan (NYSE: ELN) on the terms set out in the Proposal Announcement of February 25, 2013, but continues to be disappointed that the Board of Elan has not engaged in discussions. Royalty Pharma is ready and able to move quickly to implement an offer and believes that it will be able to complete due diligence in 20 days.

Royalty Pharma announces today that it is meeting with a number of Elan Shareholders to discuss the Proposal. For the purposes of these meetings, Royalty Pharma has produced a presentation which it is posting today on its website, and is making this announcement to conform with the disclosure and other requirements of the Irish Takeover Rules.

The presentation may be found at www.royaltypharma.com/index.php/proposedofferforelan.

Key messagesRoyalty Pharma believes that:

  • the Proposal would, if completed, allow Elan Shareholders to immediately receive full value for their Elan Stock in cash;
  • the Proposal presents a compelling financial proposition for Elan Shareholders based on a variety of different premia and multiple calculations;
  • there are significant execution risks associated with Elan's new acquisition strategy;
  • Elan's current senior management team lacks a successful track record in making acquisitions or in-licensing late stage products at Elan;
  • the Proposal attributes a higher value to the Tysabri Royalty than is implied by the terms of the Tysabri Transaction;
  • following the completion of the Tysabri Transaction, Elan will have little or no strategic value and the field of likely acquirers of Elan has narrowed sharply; and
  • the Board of Elan's refusal to engage with Royalty Pharma is depriv
    '/>"/>

  • SOURCE RP Management, LLC
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31

    Related biology technology :

    1. PDL BioPharma Provides Third Quarter 2012 Royalty Revenue Guidance of $85 Million
    2. Cowen Healthcare Royalty Partners Raises $1 Billion
    3. Array Biopharma and Global Blood Therapeutics Announce Drug Discovery Collaboration Focused on Hematology
    4. Radiopharmaceuticals Market - Global Industry Analysis, Size, Share, Trends And Forecast, 2012 - 2018: MarketResearchReports.Biz
    5. Alexandria Real Estate Equities, Inc. Announces Long-Term Lease with Leading Global Commercial-Stage Oncology Company, Onyx Pharmaceuticals, Inc., for New Build-to-Suit Facility in South San Francisco, California
    6. AVANIR Pharmaceuticals To participate in two conferences in March
    7. Favorable Scenario for Japan Pharma Industry in Coming Years, New Report Says
    8. Hyperion Wins NDA Approval for UCD Drug Developed With Support from PharmaDirections
    9. Technical Analysis on VIVUS and Achillion Pharma: Highlights on These Biotech Companies
    10. Auxilium Pharmaceuticals, Inc. Announces Fourth Quarter and Full Year 2012 Financial Results and Guidance for 2013
    11. Serialization in Pharmaceuticals, a Webinar Presented by Xtalks
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:1/15/2014)... 15, 2014 AudioNotch is the internet's ... for the treatment of tinnitus. Patients listen to sound ... over a period of weeks to months, their tinnitus volume ... two forms: Notched Music and Notched White Noise. Now, AudioNotch ...
    (Date:1/14/2014)... January 14, 2014 Carahsoft and CDS ... January 23, 2014 at 2pm EST (11am PST), “Natural ... topic focuses on how technology can turn raw, heterogeneous ... for government agencies. The online webinar will last approximately ...
    (Date:1/14/2014)... As pet owners drew up their lists of New Year,s ... better care of my furry companion." Nowadays there are pet salons, ... cases to take the little canine or feline darlings along wherever ... buy some pricey toys at the pet store. But anyone who ...
    (Date:1/14/2014)... and BETHESDA, Md. , Jan. ... together with two institutes from the National Institutes of ... for bringing safer, more effective treatments to patients on ... Center for Advancing Translational Sciences (NCATS) and the National ...
    Breaking Biology Technology:Webcast - Natural Language Processing: Converting Raw Data into Actionable Knowledge – Hosted by Carahsoft and CDS Federal Services 2New Year's Resolution: Give Pets the Gift of Top-Notch Health Care 2Organovo Announces Collaboration with National Institutes of Health 2Organovo Announces Collaboration with National Institutes of Health 3
    ... ... information company that develops and supplies irrigation management solutions. The company was approved for ... irrigation management control where “the plant is the sensor™.” , ... (Vocus) April 30, 2010 -- ...
    ... BEACH, California , and AMSTERDAM , April ... Meeting of the American Society of Breast,Surgeons, Agendia, a ... Research and Treatment has published an important study,demonstrating the ... breast cancer recurrence according to the MammaPrint test. The,ASBS ...
    ... April 29  Scotland will showcase the ... the world,s leading pharma and biotech companies to its ... in Chicago .  Heading into the conference, ... the nation,s unique integrated industry approach will continue to ...
    Cached Biology Technology:$250,000 Awarded to Smartfield, Inc. of Lubbock, TX by the Texas Emerging Technology Fund 2New Study Demonstrates Patients With High-Risk MammaPrint Profile Benefit From Chemotherapy 2New Study Demonstrates Patients With High-Risk MammaPrint Profile Benefit From Chemotherapy 3Scotland Announces New Life Science Leadership and Investments at BIO 2010 2Scotland Announces New Life Science Leadership and Investments at BIO 2010 3Scotland Announces New Life Science Leadership and Investments at BIO 2010 4
    (Date:7/9/2014)... July 9, 2014Biofuels derived from the oils produced by ... fuels. To achieve this goal, optimization of cost effective ... pond systems, is needed. Sapphire Energy has developed an ... pond algae cultivation systems, described in Industrial Biotechnology ... publishers. The article is available on the Industrial ...
    (Date:7/9/2014)... Cancer Genome Atlas (TCGA) Research Network have identified ... lung adenocarcinoma, the most common subtype of lung ... the number of possible therapeutic targets for this ... patients with treatable mutations because many potent cancer ... TCGA is jointly funded and managed by the ...
    (Date:7/9/2014)... era of increasing concern about the prevalence of ... a promising new pathway to disabling disease: blocking ... The scientists showed how bacterial siderophore, a small ... to fan bacterial growth as well as ... this infection process. Their findings appear in a ...
    Breaking Biology News(10 mins):Controlling contamination in open algae ponds for biofuels 2Study identifies novel genomic changes in the most common type of lung cancer 2Study identifies novel genomic changes in the most common type of lung cancer 3Bacteria hijack plentiful iron supply source to flourish 2
    ... American Societies for Experimental Biology (FASEB) announces the opening ... DNA in Mammalian Genomes. Mobile elements have been ... and altering functions within mammalian genomes, and continue to ... explosion of data from high throughput sources, as well ...
    ... prepared a patient to inhale a panic-inducing dose of carbon ... the mixture, she cried for help, overwhelmed by the sensation ... her 40s known as SM, has an extremely rare condition ... amygdala, an almond-shaped area in the brain long known for ...
    ... for Experimental Biology (FASEB) announces the opening of registration ... and Flagella. The 2013 Biology of Cilia ... conference where basic and translational research intersect to drive ... ciliopathies. The underlying theme of the 2013 conference is ...
    Cached Biology News:Human brain is divided on fear and panic 2Human brain is divided on fear and panic 3
    ... cytopathic effect inhibition assays, also known as CPE ... culture supernatents; serum from PK studies and delivery ... defined as the quantity of interferon required per ... infection by 50%. All standards used ...
    Request Info...
    Request Info...
    Request Info...
    Biology Products: